Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016690596> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W3016690596 abstract "Background and importance ODYSSEY is an ongoing international randomised trial evaluating dolutegravir (DTG)-based antiretroviral therapy (ART) versus standard-of-care in HIV-infected children starting first- or second-line ART. Pediatric DTG film-coated tablets (FCTs) of 10 mg and 25 mg are unavailable in low- and middle income countries (LMIC) were most HIV-infected children live. Adult DTG 50mg FTCs are produced by generic manufacturers at low-cost, are well-tolerated, and already available in many high- and LMICs. Aim and objectives Within ODYSSEY pharmacokinetic (PK) substudies were undertaken to assess PK and safety data for a simplified paediatric DTG dosing approach using WHO weight bands (WBs) 25 to Materials and methods Steady-state 24-hour PK curves were constructed from data in children (≥3 h fasted) observed taking current EMA-approved DTG doses of 25 mg and 35 mg (10 mg+25 mg FCTs)) in 25- Results 28 black-African children (52 PK profiles) from Uganda and Zimbabwe (61% male) with a median (range) age of 11.0(7.5–17.9) years old were included. For children weighing 25- Conclusions and relevance Adult 50 mg FCT once-daily dolutegravir provides appropriate PK profiles in children ≥25 kg, with no safety signal, allowing practical dosing and rapid access to dolutegravir. WHO has released new pediatric dosing guidelines in response to these results." @default.
- W3016690596 created "2020-04-24" @default.
- W3016690596 creator A5001333478 @default.
- W3016690596 creator A5004178700 @default.
- W3016690596 creator A5006114405 @default.
- W3016690596 creator A5007773291 @default.
- W3016690596 creator A5015306937 @default.
- W3016690596 creator A5023193867 @default.
- W3016690596 creator A5023749807 @default.
- W3016690596 creator A5030902925 @default.
- W3016690596 creator A5037936527 @default.
- W3016690596 creator A5038416217 @default.
- W3016690596 creator A5047248287 @default.
- W3016690596 creator A5054311317 @default.
- W3016690596 creator A5054506620 @default.
- W3016690596 creator A5059245006 @default.
- W3016690596 creator A5061093319 @default.
- W3016690596 creator A5088210610 @default.
- W3016690596 creator A5089598226 @default.
- W3016690596 creator A5090095722 @default.
- W3016690596 date "2020-03-01" @default.
- W3016690596 modified "2023-09-26" @default.
- W3016690596 title "NP-003 Steady-state pharmacokinetics and early safety data in HIV-infected african children weighing ≥25 kg after switching to 50 mg film-coated dolutegravir tablets in the ODYSSEY trial" @default.
- W3016690596 doi "https://doi.org/10.1136/ejhpharm-2020-eahpconf.461" @default.
- W3016690596 hasPublicationYear "2020" @default.
- W3016690596 type Work @default.
- W3016690596 sameAs 3016690596 @default.
- W3016690596 citedByCount "0" @default.
- W3016690596 crossrefType "proceedings-article" @default.
- W3016690596 hasAuthorship W3016690596A5001333478 @default.
- W3016690596 hasAuthorship W3016690596A5004178700 @default.
- W3016690596 hasAuthorship W3016690596A5006114405 @default.
- W3016690596 hasAuthorship W3016690596A5007773291 @default.
- W3016690596 hasAuthorship W3016690596A5015306937 @default.
- W3016690596 hasAuthorship W3016690596A5023193867 @default.
- W3016690596 hasAuthorship W3016690596A5023749807 @default.
- W3016690596 hasAuthorship W3016690596A5030902925 @default.
- W3016690596 hasAuthorship W3016690596A5037936527 @default.
- W3016690596 hasAuthorship W3016690596A5038416217 @default.
- W3016690596 hasAuthorship W3016690596A5047248287 @default.
- W3016690596 hasAuthorship W3016690596A5054311317 @default.
- W3016690596 hasAuthorship W3016690596A5054506620 @default.
- W3016690596 hasAuthorship W3016690596A5059245006 @default.
- W3016690596 hasAuthorship W3016690596A5061093319 @default.
- W3016690596 hasAuthorship W3016690596A5088210610 @default.
- W3016690596 hasAuthorship W3016690596A5089598226 @default.
- W3016690596 hasAuthorship W3016690596A5090095722 @default.
- W3016690596 hasBestOaLocation W30166905961 @default.
- W3016690596 hasConcept C112705442 @default.
- W3016690596 hasConcept C142462285 @default.
- W3016690596 hasConcept C159047783 @default.
- W3016690596 hasConcept C187212893 @default.
- W3016690596 hasConcept C2777288759 @default.
- W3016690596 hasConcept C2779502633 @default.
- W3016690596 hasConcept C2993143319 @default.
- W3016690596 hasConcept C3013748606 @default.
- W3016690596 hasConcept C71924100 @default.
- W3016690596 hasConcept C98274493 @default.
- W3016690596 hasConceptScore W3016690596C112705442 @default.
- W3016690596 hasConceptScore W3016690596C142462285 @default.
- W3016690596 hasConceptScore W3016690596C159047783 @default.
- W3016690596 hasConceptScore W3016690596C187212893 @default.
- W3016690596 hasConceptScore W3016690596C2777288759 @default.
- W3016690596 hasConceptScore W3016690596C2779502633 @default.
- W3016690596 hasConceptScore W3016690596C2993143319 @default.
- W3016690596 hasConceptScore W3016690596C3013748606 @default.
- W3016690596 hasConceptScore W3016690596C71924100 @default.
- W3016690596 hasConceptScore W3016690596C98274493 @default.
- W3016690596 hasLocation W30166905961 @default.
- W3016690596 hasOpenAccess W3016690596 @default.
- W3016690596 hasPrimaryLocation W30166905961 @default.
- W3016690596 hasRelatedWork W11219607 @default.
- W3016690596 hasRelatedWork W12104161 @default.
- W3016690596 hasRelatedWork W13182942 @default.
- W3016690596 hasRelatedWork W13516814 @default.
- W3016690596 hasRelatedWork W1795123 @default.
- W3016690596 hasRelatedWork W18157491 @default.
- W3016690596 hasRelatedWork W18252752 @default.
- W3016690596 hasRelatedWork W19234638 @default.
- W3016690596 hasRelatedWork W20849877 @default.
- W3016690596 hasRelatedWork W6516669 @default.
- W3016690596 isParatext "false" @default.
- W3016690596 isRetracted "false" @default.
- W3016690596 magId "3016690596" @default.
- W3016690596 workType "article" @default.